|Min SIP Amount||₹500|
|NAV||₹147.14 (19 Jan 2021)|
|Fund Started||01 Jan 2013|
|Fund Size||₹4,727 Cr|
|PI Industries Ltd.||Chemicals||Equity||3.5%|
|Jubilant FoodWorks Ltd.||Services||Equity||3.3%|
|Cholamandalam Investment & Finance Co. Ltd.||Financial||Equity||3.1%|
|Syngene International Ltd.||Healthcare||Equity||2.4%|
|Tube Investments Of India Ltd.||Automobile||Equity||2.3%|
|Apollo Hospitals Enterprise Ltd.||Healthcare||Equity||2.3%|
|Info Edge (India) Ltd.||Services||Equity||2.3%|
UTI Mid Cap Fund Direct Growth is a Equity Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 01 Jan 2013. Lalit Nambiar is the Current Fund Manager of UTI Mid Cap Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹4,727 Cr and the Latest NAV as of 19 Jan 2021 is ₹147.14.
The UTI Mid Cap Fund Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed less than 1 year
The scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of mid cap companies.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.